Passive immunity in prevention and treatment of infectious diseases.

Antibodies have been used for over a century in the prevention and treatment of infectious disease. They are used most commonly for the prevention of measles, hepatitis A, hepatitis B, tetanus, varicella, rabies, and vaccinia. Although their use in the treatment of bacterial infection has largely been supplanted by antibiotics, antibodies remain a critical component of the treatment of diptheria, tetanus, and botulism. High-dose intravenous immunoglobulin can be used to treat certain viral infections in immunocompromised patients (e.g., cytomegalovirus, parvovirus B19, and enterovirus infections). Antibodies may also be of value in toxic shock syndrome, Ebola virus, and refractory staphylococcal infections. Palivizumab, the first monoclonal antibody licensed (in 1998) for an infectious disease, can prevent respiratory syncytial virus infection in high-risk infants. The development and use of additional monoclonal antibodies to key epitopes of microbial pathogens may further define protective humoral responses and lead to new approaches for the prevention and treatment of infectious diseases.

[1]  W. L. Bradford.  USE OF CONVALESCENT BLOOD IN WHOOPING COUGH: WITH A REVIEW OF THE LITERATURE , 1935 .

[2]  P. Stastny,et al.  Role of infection in mortality from severe burns. Evaluation of plasma, gamma-globulin, albumin and saline-solution therapy in a group of Peruvian children. , 1962, The New England journal of medicine.

[3]  G. Storch.  Humanized monoclonal antibody for prevention of respiratory syncytial virus infection. , 1998, Pediatrics.

[4]  T. Sasaki,et al.  Successful treatment of Epstein-Barr virus infection with ganciclovir and cytomegalovirus hyperimmune globulin following kidney transplantation. , 1995, Transplantation proceedings.

[5]  B. Waisbren.  The treatment of bacterial infections with the combination of antibiotics and gamma globulin. , 1957, Antibiotics & chemotherapy.

[6]  C. Tremblay,et al.  Clinical usefulness of intravenous human immunoglobulins in invasive group A Streptococcal infections: case report and review. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[7]  D. Morris,et al.  Failure of Hyperimmune Gamma Globulin to Prevent Whooping Cough , 1957, Archives of disease in childhood.

[8]  L. Wright,et al.  Respiratory syncytial virus immune globulin intravenous: Indications for use , 1997 .

[9]  H. E. Alexander.  TREATMENT OF HAEMOPHILUS INFLUENZAE INFECTIONS AND OF MENINGOCOCCIC AND PNEUMOCOCCIC MENINGITIS , 1943 .

[10]  J. Lambert,et al.  Efficacy of zidovudine and human immunodeficiency virus (HIV) hyperimmune immunoglobulin for reducing perinatal HIV transmission from HIV-infected women with advanced disease: results of Pediatric AIDS Clinical Trials Group protocol 185. , 1999, The Journal of infectious diseases.

[11]  A. Corwin,et al.  Experience with the use of an investigational F(ab')2 heptavalent botulism immune globulin of equine origin during an outbreak of type E botulism in Egypt. , 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[12]  Nonmenstrual toxic shock syndrome: new insights into diagnosis, pathogenesis, and treatment. , 1996, Current clinical topics in infectious diseases.

[13]  Henry Nider,et al.  Report of the Committee on Infectious Diseases , 1989 .

[14]  R. Hamilton,et al.  Humanized antibodies as potential therapeutic drugs. , 1998, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[15]  O. Ramilo,et al.  Reduction of respiratory syncytial virus (RSV) in tracheal aspirates in intubated infants by use of humanized monoclonal antibody to RSV F protein. , 1998, The Journal of infectious diseases.

[16]  J. Stokes,et al.  The Use of Human Immune Serum Globulin (Gamma Globulin) in Infectious (Epidemic) Hepatitis in the Mediterranean Theater of Operations. II. Studies on Treatment in an Epidemic of Infectious Hepatitis. , 1945 .

[17]  Tutschka Pj.  Infections and immunodeficiency in bone marrow transplantation. , 1988 .

[18]  L. Mofenson,et al.  Use of human immunodeficiency virus (HIV) human hyperimmune immunoglobulin in HIV type 1-infected children (Pediatric AIDS clinical trials group protocol 273). , 2000, The Journal of infectious diseases.

[19]  B. Feery,et al.  The Efficacy of Vaccinial Immune Globulin , 1976 .

[20]  T. Monath,et al.  Intranasal Antibody Prophylaxis for Protection against Viral Disease , 1999, Clinical Microbiology Reviews.

[21]  J. Abkowitz,et al.  Persistent B19 parvovirus infection in patients infected with human immunodeficiency virus type 1 (HIV-1): a treatable cause of anemia in AIDS. , 1990, Annals of internal medicine.

[22]  J. Barkun,et al.  Recurrence-free long-term survival after liver transplantation for hepatitis B using interferon-alpha pretransplant and hepatitis B immune globulin posttransplant. , 1997, Annals of surgery.

[23]  J. McCutchan,et al.  TREATMENT OF GRAM-NEGATIVE BACTEREMIA AND SHOCK WITH HUMAN ANTISERUM TO A MUTANT ESCHERICHIA COLI , 1983 .

[24]  R. Knodell,et al.  EFFICACY OF PROPHYLACTIC GAMMA-GLOBULIN IN PREVENTING NON-A, NON-B POST-TRANSFUSION HEPATITIS , 1976, The Lancet.

[25]  H. Hill,et al.  Effect on neutrophil kinetics and serum opsonic capacity of intravenous administration of immune globulin to neonates with clinical signs of early-onset sepsis. , 1991, The Journal of pediatrics.

[26]  E. R. Stiehm,et al.  Appropriate therapeutic use of immunoglobulin. , 1996, Transfusion medicine reviews.

[27]  C. Teter,et al.  Chronic pure red cell aplasia caused by parvovirus B19 in AIDS: Use of intravenous immunoglobulin—A report of eight patients , 1999, American journal of hematology.

[28]  Y. Matsumoto,et al.  Intraperitoneal administration of cytomegalovirus hyperimmunoglobulin to the cytomegalovirus-infected fetus. , 1998, Journal of Perinatology.

[29]  Cytomegalovirus infection in kidney transplantation: prophylaxis and management. , 1996, Transplantation proceedings.

[30]  M. Wilcox.  Treatment of Clostridium difficile infection. , 1998, The Journal of antimicrobial chemotherapy.

[31]  M. Leal,et al.  PREVENTION OF POST-TRANSFUSION NON-A, NON-B HEPATITIS BY NON-SPECIFIC IMMUNOGLOBULIN IN HEART SURGERY PATIENTS , 1988, The Lancet.

[32]  R. Feigin,et al.  Textbook of Pediatric Infectious Diseases , 1986 .

[33]  John E. Bennett,et al.  Principles and practice of infectious diseases. Vols 1 and 2. , 1979 .

[34]  A. Cross,et al.  Production and characterization of a human hyperimmune intravenous immunoglobulin against Pseudomonas aeruginosa and Klebsiella species. , 1991, The Journal of infectious diseases.

[35]  B. Charpentier,et al.  Human parvovirus B19 infection in organ transplant recipients , 1999, Clinical transplantation.

[36]  K. Sullivan,et al.  Reduction in transplant-related complications in patients given intravenous immuno globulin after allogeneic marrow transplantation. , 1994, Clinical and experimental immunology.

[37]  R. Pollard,et al.  Immunotherapy of CMV infections. , 1996, Advances in experimental medicine and biology.

[38]  T. Drake.  Recommendations for protection against viral hepatitis , 1986 .

[39]  S. Chevret,et al.  Passive immunotherapy in AIDS: a double-blind randomized study based on transfusions of plasma rich in anti-human immunodeficiency virus 1 antibodies vs. transfusions of seronegative plasma. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[40]  S. Solomon,et al.  Outbreak of echovirus 11 infection in hospitalized neonates. , 1988, The Pediatric infectious disease journal.

[41]  A. Wilkinson,et al.  CONSERVATIVE MANAGEMENT OF AN ECHOVIRUS 11 OUTBREAK IN A NEONATAL UNIT , 1989, The Lancet.

[42]  J. Sharp,et al.  Experience of anti-vaccinia immunoglobulin in the United Kingdom. , 1973, Lancet.

[43]  Samuel R. Wilson,et al.  Opsonic antibodies to Staphylococcus epidermidis: in vitro and in vivo studies using human intravenous immune globulin. , 1994, The Journal of infectious diseases.

[44]  R. Gelber,et al.  A controlled trial of intravenous immune globulin for the prevention of serious bacterial infections in children receiving zidovudine for advanced human immunodeficiency virus infection. Pediatric AIDS Clinical Trials Group. , 1994, The New England journal of medicine.

[45]  A. Casadevall,et al.  Return to the Past: The Case for Antibody-Based Therapies in Infectious Diseases , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[46]  Cytomegalovirus prophylaxis with ganciclovir, acyclovir, and CMV hyperimmune globulin in liver transplant patients receiving OKT3 induction. , 1995, Transplantation proceedings.

[47]  N. Young.  Parvovirus infection and its treatment , 1996, Clinical and experimental immunology.

[48]  M. Abinun,et al.  Intravenous immunoglobulin prophylaxis in an echovirus 6 and echovirus 4 nursery outbreak. , 1997, The Pediatric infectious disease journal.

[49]  W. Siegert,et al.  Treatment with ganciclovir and Ig for acute Epstein-Barr virus infection after allogeneic bone marrow transplantation. , 1993, Blood.

[50]  C. Berg,et al.  Abortion surveillance--United States, 1999. , 2002, Morbidity and mortality weekly report. Surveillance summaries.

[51]  R. Buchdahl,et al.  Toxic shock syndrome. , 1985, The Journal of the Arkansas Medical Society.

[52]  T. Chuhjo,et al.  Successful treatment of persistent erythroid aplasia caused by parvovirus B19 infection in a patient with common variable immunodeficiency with low‐dose immunoglobulin , 1999, American journal of hematology.

[53]  C. Pothoulakis,et al.  Intravenous immunoglobulin therapy for severe Clostridium difficile colitis , 1997, Gut.

[54]  S. Govindarajan,et al.  The use of vaccinia hyperimmune gamma-globulin in the prophylaxis of smallpox. , 1961, Bulletin of the World Health Organization.

[55]  E. Simões,et al.  Respiratory syncytial virus-enriched globulin for the prevention of acute otitis media in high risk children. , 1996, The Journal of pediatrics.

[56]  S. Donta,et al.  Intravenous immunoglobulin therapy for toxic shock syndrome. , 1992, JAMA.

[57]  P. Whitley-Williams,et al.  Clinical immunology and infectious diseases. , 1994, Pediatric clinics of North America.

[58]  B. Pollock,et al.  Meta-analyses of the effectiveness of intravenous immune globulin for prevention and treatment of neonatal sepsis. , 1997, Pediatrics.

[59]  J. McCutchan,et al.  PREVENTION OF GRAM-NEGATIVE SHOCK AND DEATH IN SURGICAL PATIENTS BY ANTIBODY TO ENDOTOXIN CORE GLYCOLIPID , 1985, The Lancet.

[60]  The French National Registry of HA-1A (Centoxin) in septic shock. A cohort study of 600 patients. The National Committee for the Evaluation of Centoxin. , 1994, Archives of internal medicine.

[61]  Johnston Jm,et al.  Intravenous immunoglobulin in disseminated neonatal echovirus 11 infection. , 1989 .

[62]  T. Lamparelli,et al.  A randomized trial of high dose polyvalent intravenous immunoglobulin (HDIgG) vs. Cytomegalovirus (CMV) hyperimmune IgG in allogeneic hemopoietic stem cell transplants (HSCT). , 1998, Haematologica.

[63]  B. Schwartz,et al.  Severe Invasive Group A Streptococcal Infections: A Subject Review , 1998, Pediatrics.

[64]  Waisbren Ba.  The treatment of bacterial infections with the combination of antibiotics and gamma globulin. , 1957 .

[65]  J. Moye,et al.  Prophylactic intravenous immunoglobulin in HIV-infected children with CD4+ counts of 0.20 x 10(9)/L or more. Effect on viral, opportunistic, and bacterial infections. The National Institute of Child Health and Human Development Intravenous Immunoglobulin Clinical Trial Study Group. , 1992, JAMA.

[66]  D. Snydman,et al.  Cytomegalovirus prophylaxis in solid organ transplant recipients. , 1996, Transplantation.

[67]  G. Barbero,et al.  Vaccinia gangrenosa treated with hyperimmune vaccinal gamma globulin. , 1955, Pediatrics.

[68]  Jaap M Middeldorp,et al.  Immunoglobulins in the prophylaxis of parvovirus B19 infection. , 1990, The Journal of infectious diseases.

[69]  Toxic Shock Syndrome after Staphylococcal Pneumonia Treated with Intravenous Immunoglobulin , 1995, Vox sanguinis.

[70]  P. Ruutu,et al.  No prevention of cytomegalovirus infection by anti-cytomegalovirus hyperimmune globulin in seronegative bone marrow transplant recipients , 1997, Bone Marrow Transplantation.

[71]  M. Haeney.  The role of the complement cascade in sepsis. , 1998, The Journal of antimicrobial chemotherapy.

[72]  Martin L. Lee,et al.  Prophylactic intravenous administration of standard immune globulin as compared with core-lipopolysaccharide immune globulin in patients at high risk of postsurgical infection. , 1992, The New England journal of medicine.

[73]  C. Kempe.  Studies on Smallpox and Complications of Smallpox Vaccination. E. Mead Johnson Award Address. , 1960 .

[74]  M. Melish,et al.  Vaginal tampon model for toxic shock syndrome. , 1989, Reviews of infectious diseases.

[75]  E. Cosmi,et al.  Hyperimmunoglobulin therapy for a twin fetus with cytomegalovirus infection and growth restriction. , 1999, American journal of obstetrics and gynecology.

[76]  G. Siber,et al.  Protective Effects of Pertussis Immunoglobulin (P-IGIV) in the Aerosol Challenge Model , 1999, Clinical Diagnostic Laboratory Immunology.

[77]  Caroline C. Johnson,et al.  Immunoprophylaxis against Klebsiella and Pseudomonas aeruginosa Infections , 1996 .

[78]  M. Ballow.  Mechanisms of action of intravenous immune serum globulin in autoimmune and inflammatory diseases. , 1997, The Journal of allergy and clinical immunology.

[79]  A. Norrby-Teglund,et al.  Varying titers of neutralizing antibodies to streptococcal superantigens in different preparations of normal polyspecific immunoglobulin G: implications for therapeutic efficacy. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[80]  M. Santosham,et al.  Prevention of Haemophilus influenzae type b infections in high-risk infants treated with bacterial polysaccharide immune globulin. , 1987, The New England journal of medicine.

[81]  J. Nagington,et al.  USE OF NORMAL IMUNOGLOBULIN IN AN ECHOVIRUS 11 OUTBREAK IN A SPECIAL-CARE BABY UNIT , 1983, The Lancet.

[82]  [Secondary immunodeficiencies]. , 1999, Sangre.

[83]  U. Schaad,et al.  Aerosolized immunoglobulin treatment of respiratory syncytial virus infection in infants. , 1996, The Pediatric infectious disease journal.

[84]  Owings Mills,et al.  Infectious hepatitis; length of protection by immune serum globulin (gamma globulin) during epidemics. , 1951 .

[85]  B. Guglielmo,et al.  Immune globulin therapy in allogeneic bone marrow transplant: a critical review. , 1994, Bone marrow transplantation.

[86]  D. Samuel,et al.  HBV infection after liver transplantation in HBsAg positive patients: experience with long-term immunoprophylaxis. , 1991, Transplantation proceedings.

[87]  P. Amerio,et al.  Intravenous immunoglobulins suppress the recurrences of genital herpes simplex virus: a clinical and immunological study. , 1995, Immunopharmacology and immunotoxicology.

[88]  G. Thiele,et al.  Immunovirological studies of fatal infectious mononucleosis in a patient with X-linked lymphoproliferative syndrome treated with intravenous immunoglobulin and interferon-alpha. , 1990, Clinical immunology and immunopathology.

[89]  Hanshaw Jb,et al.  Varicella-Zoster Infections , 2015, Red Book (2015).

[90]  S. Katz,et al.  CHRONIC ENTEROVIRAL MENINGOENCEPHALITIS IN AGAMMAGLOBULINEMIC PATIENTS , 1988 .

[91]  H. Qureshi.  Postexposure prophylaxis of hepatitis B. , 1988, JPMA. The Journal of the Pakistan Medical Association.

[92]  B. Pollock,et al.  The role of intravenous immunoglobulin for the prevention and treatment of neonatal sepsis. , 1998, Seminars in perinatology.

[93]  F. Smaill,et al.  Use of immune globulin to prevent symptomatic cytomegalovirus disease in transplant recipients--a meta-analysis. , 1994, Clinical transplantation.

[94]  J. Zaia.  Prevention and treatment of cytomegalovirus pneumonia in transplant recipients. , 1993, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[95]  J. Griffith,et al.  Cytomegalovirus immune globulin (CMVIG) prophylaxis is associated with increased survival after orthotopic liver transplantation. The Boston Center for Liver Transplantation CMVIG Study Group. , 1997, Clinical transplantation.

[96]  Varicella-Zoster Infection , 1973 .

[97]  S. Miyazaki,et al.  Treatment of severe pertussis by administration of specific gamma globulin with high titers anti‐toxin antibody , 1993, Acta paediatrica.

[98]  The efficacy of vaccinial immune globulin. A 15-year study. , 1976, Vox sanguinis.

[99]  J. Dwyer,et al.  Intraventricular gamma‐globulin for the management of enterovirus encephalitis , 1988, The Pediatric infectious disease journal.

[100]  Smego Ra,et al.  Use of Acyclovir for Varicella Pneumonia During Pregnancy , 1991, Obstetrics and gynecology.

[101]  K. Nelson,et al.  Treatment of pertussis with pertussis immune globulin. , 1971, The Journal of pediatrics.

[102]  E. Stiehm,et al.  Immunologic disorders in infants and children , 1973 .

[103]  Summary of the workshop on passive immunotherapy in the prevention and treatment of HIV infection. The Passive Antibody Workshop Participants. , 1995, Clinical immunology and immunopathology.

[104]  W. Nanning.  Prophylactic effect of antivaccinia gamma-globulin against post-vaccinal encephalitis. , 1962, Bulletin of the World Health Organization.

[105]  J. Wittes,et al.  Meta-analysis of CMVIG studies for the prevention and treatment of CMV infection in transplant patients. , 1996, Transplantation proceedings.

[106]  M Krajden,et al.  Clinical practice guidelines: prevention of cytomegalovirus disease after renal transplantation. , 1998, Journal of the American Society of Nephrology : JASN.

[107]  PREVENTION OF NON-A, NON-B HEPATITIS IN HAEMODIALYSIS PATIENTS BY HEPATITIS B IMMUNOGLOBULIN , 1984, The Lancet.

[108]  J. Kleinstein.  Active and Passive Immunization. , 1938, California and western medicine.

[109]  W. Shearer,et al.  A CONTROLLED TRIAL OF INTRAVENOUS IMMUNE GLOBULIN FOR THE PREVENTION OF SERIOUS BACTERIAL INFECTIONS IN CHILDREN RECEIVING ZIDOVUDINE FOR ADVANCED HUMAN IMMUNODEFICIENCY VIRUS INFECTION , 1995, Pediatrics.

[110]  A. Levey,et al.  Use of cytomegalovirus immune globulin to prevent cytomegalovirus disease in renal-transplant recipients. , 1987, The New England journal of medicine.

[111]  A. Casadevall.  Passive antibody therapies: progress and continuing challenges. , 1999, Clinical immunology.

[112]  C. Pothoulakis,et al.  Treatment with intravenously administered gamma globulin of chronic relapsing colitis induced by Clostridium difficile toxin. , 1991, The Journal of pediatrics.

[113]  J. Pennington,et al.  Pseudomonas hyperimmune globulin passive immunotherapy for pulmonary exacerbations in cystic fibrosis , 1990, Pediatric pulmonology.

[114]  S. Nasraway,et al.  Efficacy and safety of monoclonal antibody to human tumor necrosis factor alpha in patients with sepsis syndrome. A randomized, controlled, double-blind, multicenter clinical trial. TNF-alpha MAb Sepsis Study Group. , 1995, JAMA.

[115]  R. Sokol,et al.  Fulminant Epstein-Barr viral hepatitis: orthotopic liver transplantation and review of the literature. , 1998, Liver transplantation and surgery : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[116]  J. Carlet,et al.  INTERSEPT: an international, multicenter, placebo-controlled trial of monoclonal antibody to human tumor necrosis factor-alpha in patients with sepsis. International Sepsis Trial Study Group. , 1996, Critical care medicine.

[117]  M. Dhalla,et al.  Treatment of severe pertussis: a study of the safety and pharmacology of intravenous pertussis immunoglobulin. , 1999, The Pediatric infectious disease journal.

[118]  J. Schellekens,et al.  Treatment of gram-negative septic shock with human IgG antibody to Escherichia coli J5: a prospective, double-blind, randomized trial. , 1988, The Journal of infectious diseases.

[119]  J. Flynn,et al.  Intravenous immunoglobulin prophylaxis of cytomegalovirus infection in pediatric renal transplant recipients. , 1997, American Journal of Nephrology.

[120]  A. Chepurnov,et al.  Preparation and use of hyperimmune serum for prophylaxis and therapy of Ebola virus infections. , 1999, The Journal of infectious diseases.

[121]  M. Stazi,et al.  Sexual transmission of the hepatitis C virus and efficacy of prophylaxis with intramuscular immune serum globulin. A randomized controlled trial. , 1997, Archives of internal medicine.

[122]  M. Sterne.  Clostridial infections. , 2018, The British veterinary journal.

[123]  L. Wright,et al.  Prevention of Respiratory Syncytial Virus Infections: Indications for the Use of Palivizumab and Update on the Use of RSV-IGIV , 1998, Pediatrics.

[124]  J. Lévy,et al.  Passive hyperimmune plasma therapy in the treatment of acquired immunodeficiency syndrome: results of a 12-month multicenter double-blind controlled trial. The Passive Hyperimmune Therapy Study Group. , 1994, Blood.

[125]  D. Swerdlow,et al.  Botulism in the United States: A Clinical and Epidemiologic Review , 1998, Annals of Internal Medicine.

[126]  S. Goodman,et al.  Efficacy of immune globulin in preventing complications of bone marrow transplantation: a meta-analysis. , 1993, Bone marrow transplantation.

[127]  G. V. Van Hare,et al.  Bacterial polysaccharide immune globulin for prophylaxis of acute otitis media in high-risk children. , 1993, The Journal of pediatrics.

[128]  R. Colebunders,et al.  Treatment of Ebola hemorrhagic fever with blood transfusions from convalescent patients. International Scientific and Technical Committee. , 1999, The Journal of infectious diseases.

[129]  H. Lederman,et al.  Anti-tetanus toxoid antibodies in intravenous gamma globulin: an alternative to tetanus immune globulin. , 1992, The Journal of infectious diseases.

[130]  A. Ohlsson,et al.  Administration of intravenous immunoglobulins for prophylaxis or treatment of infection in preterm infants: meta-analyses. , 1995, Archives of disease in childhood. Fetal and neonatal edition.

[131]  A P Wheeler,et al.  Treating patients with severe sepsis. , 1999, The New England journal of medicine.

[132]  J. Englund,et al.  Combination therapy with aerosolized ribavirin and intravenous immunoglobulin for respiratory syncytial virus disease in adult bone marrow transplant recipients. , 1995, Bone marrow transplantation.

[133]  G. Edsall.  PASSIVE IMMUNIZATION. , 1963, Pediatrics.

[134]  W. Dankner.  Reduction of Respiratory Syncytial Virus Hospitalization Among Premature Infants and Infants with Bronchopulmonary Dysplasia Using Respiratory Syncytial Virus Immune Globulin Prophylaxis , 1997, Pediatrics.

[135]  A. Arvin.  Varicella Zoster Virus , 2002 .

[136]  H Gordan,et al.  Herpes simplex. , 1982, International journal of dermatology.

[137]  P. Jahrling,et al.  Passive immunization of Ebola virus-infected cynomolgus monkeys with immunoglobulin from hyperimmune horses. , 1996, Archives of virology. Supplementum.

[138]  A. Selbing,et al.  Parvovirus B19 infection during pregnancy treated with high-dose intravenous gammaglobulin , 1995, The Lancet.

[139]  W. Gruber,et al.  Respiratory syncytial virus (RSV) immune globulin intravenous therapy for RSV lower respiratory tract infection in infants and young children at high risk for severe RSV infections: Respiratory Syncytial Virus Immune Globulin Study Group. , 1997, Pediatrics.

[140]  V. Sitprija,et al.  Failure of postexposure treatment of rabies in children. , 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[141]  P. Yap,et al.  Use of intravenous immunoglobulin to prevent or treat infections in persons with immune deficiency. , 1997, Annual review of medicine.

[142]  R. Bégué,et al.  Failure of intrathecal tetanus antitoxin in the treatment of tetanus neonatorum. , 1991, The Journal of infectious diseases.

[143]  Palivizumab, a Humanized Respiratory Syncytial Virus Monoclonal Antibody, Reduces Hospitalization From Respiratory Syncytial Virus Infection in High-risk Infants. , 1998, Pediatrics.

[144]  The effect of intravenous immunoglobulin and interferon-alpha on Epstein-Barr virus-induced lymphoproliferative disorder in a liver transplant recipient. , 1994, Transplantation.

[145]  W. Gruber,et al.  Respiratory syncytial virus immune globulin treatment of RSV lower respiratory tract infection in previously healthy children. , 1997, Pediatrics.

[146]  M. Ogilvie.  Antiviral prophylaxis and treatment in chickenpox. A review prepared for the UK Advisory Group on Chickenpox on behalf of the British Society for the Study of Infection. , 1998, The Journal of infection.

[147]  C. Hall,et al.  Prophylactic Administration of Respiratory Syncytial Virus Immune Globulin to High-Risk Infants and Young Children , 1993 .

[148]  G. Alexander,et al.  Liver transplantation in European patients with the hepatitis B surface antigen. , 1993, The New England journal of medicine.

[149]  D. Schillinger.  Postexposure prophylaxis of hepatitis B. , 1984, MMWR. Morbidity and mortality weekly report.

[150]  J. Paul,et al.  PREVENTION OF INFECTIOUS HEPATITIS WITH GAMMA GLOBULIN , 1945 .

[151]  Yap Pl,et al.  USE OF INTRAVENOUS IMMUNOGLOBULIN TO PREVENT OR TREAT INFECTIONS IN PERSONS WITH IMMUNE DEFICIENCY , 1997 .

[152]  M. W. Fisher.  Synergism between human gamma globulin and chloramphenicol in the treatment of experimental bacterial infections. , 1957, Antibiotics & chemotherapy.

[153]  K. Theobald,et al.  Vaccination against tick-borne encephalitis (TBE): influence of simultaneous application of TBE immunoglobulin on seroconversion and rate of adverse events. , 1995, Vaccine.

[154]  J. Clemens,et al.  Passive immunotherapy in the treatment of advanced human immunodeficiency virus infection. , 1993, The Journal of infectious diseases.

[155]  E. Simões,et al.  Respiratory syncytial virus (RSV) infection in preterm infants and the protective effects of RSV immune globulin (RSVIG). Respiratory Syncytial Virus Immune Globulin Study Group. , 1995, Pediatrics.

[156]  A. Messori,et al.  Efficacy of hyperimmune anti-cytomegalovirus immunoglobulins for the prevention of cytomegalovirus infection in recipients of allogeneic bone marrow transplantation: a meta-analysis. , 1994, Bone marrow transplantation.

[157]  B. Pollock,et al.  Intravenous immune globulin for the prevention of nosocomial infection in low‐birth‐weight neonates , 1993 .

[158]  M. Krajden,et al.  Cytomegalovirus viremia in lung transplant recipients receiving ganciclovir and immune globulin. , 1998, Chest.

[159]  B. K. Jain,et al.  INTRATHECAL HUMAN TETANUS IMMUNOGLOBULIN IN EARLY TETANUS , 1980, The Lancet.

[160]  R. Whitley.  Neonatal herpes simplex virus infections: is there a role for immunoglobulin in disease prevention and therapy? , 1994, The Pediatric infectious disease journal.

[161]  D. Samuel,et al.  Incidence of Hepatitis C in Patients Receiving Different Preparations of Hepatitis B Immunoglobulins after Liver Transplantation , 1998, Annals of Internal Medicine.

[162]  [TBE-immunoglobulins--a critical assessment of efficacy]. , 1994, Schweizerische medizinische Wochenschrift.

[163]  W. Gruber,et al.  Respiratory Syncytial Virus (RSV) Immune Globulin Intravenous Therapy for RSV Lower Respiratory Tract Infection in Infants and Young Children at High Risk for Severe RSV Infections , 1997 .

[164]  L. Mofenson,et al.  Intravenous immune globulin for the prevention of bacterial infections in children with symptomatic human immunodeficiency virus infection. , 1991, The New England journal of medicine.

[165]  J. Towbin,et al.  Outcomes among pediatric heart transplant recipients after dual-therapy cytomegalovirus prophylaxis , 1997 .

[166]  E. Reed,et al.  Treatment of cytomegalovirus pneumonia with ganciclovir and intravenous cytomegalovirus immunoglobulin in patients with bone marrow transplants. , 1988, Annals of internal medicine.

[167]  P. Jahrling,et al.  Evaluation of immune globulin and recombinant interferon-alpha2b for treatment of experimental Ebola virus infections. , 1999, The Journal of infectious diseases.

[168]  R. I. Schiff.  Transmission of viral infections through intravenous immune globulin. , 1994, The New England journal of medicine.

[169]  L. Givner.  Monoclonal antibodies against respiratory syncytial virus. , 1999, The Pediatric infectious disease journal.

[170]  Role of immunoglobulins and new antivirals in treatment of cytomegalovirus infection. , 1995, Transplantation proceedings.

[171]  M. Granström,et al.  Specific immunoglobulin for treatment of whooping cough , 1991, The Lancet.

[172]  P. Chesney,et al.  Toxic-shock syndrome: epidemiologic features, recurrence, risk factors, and prevention. , 1980, The New England journal of medicine.

[173]  P. Karna,et al.  Use of Intravenous Immunoglobulin In Twin Neonates With Disseminated Coxsackie B1 Infection , 1993, Clinical pediatrics.

[174]  Vaccinia (smallpox) vaccine. Recommendations of the Immunization Practices Advisory Committee (ACIP) , 1991, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[175]  T. Merigan,et al.  Zoster immune globulin prophylaxis of disseminated zoster in compromised hosts. A randomized trial. , 1980, Archives of internal medicine.

[176]  J. Overall,et al.  Intravenous immunoglobulin in disseminated neonatal echovirus 11 infection. , 1989, The Pediatric infectious disease journal.

[177]  A. Eidelman,et al.  Neonatal coxsackievirus group B infections: experience of a single department of neonatology. , 1994, Israel journal of medical sciences.

[178]  R. Cowan,et al.  Intravenous immune globulin treatment of pulmonary exacerbations in cystic fibrosis. , 1989, The Journal of pediatrics.

[179]  J. Stokes,et al.  THE PREVENTION AND ATTENUATION OF INFECTIOUS HEPATITIS BY GAMMA GLOBULIN: PRELIMINARY NOTE , 1945 .

[180]  R. Rozenshteyn,et al.  Characterization of a Type-Common Human Recombinant Monoclonal Antibody to Herpes Simplex Virus with High Therapeutic Potential , 1998, Journal of Clinical Microbiology.

[181]  Fisher Mw.  Synergism between human gamma globulin and chloramphenicol in the treatment of experimental bacterial infections. , 1957 .

[182]  P. Pinsky,et al.  Risk factors associated with echovirus 11' infection in a hospital nursery , 1986, Pediatric infectious disease.

[183]  M. Levin,et al.  Neonatal enterovirus infection: virology, serology, and effects of intravenous immune globulin. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[184]  W. Rawlinson,et al.  Progressive vaccinia treated with ribavirin and vaccinia immune globulin. , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[185]  P. Arguin.  Human rabies prevention -- United States, 1999 : recommendations of the Advisory Committee on Immunization Practices (ACIP) , 1999 .

[186]  A. Finn.  Immunologic Disorders in Infants and Children. , 1997 .

[187]  S. Zolla-Pazner,et al.  Generation of Neutralizing Human Monoclonal Antibodies against Parvovirus B19 Proteins , 1999, Journal of Virology.

[188]  M. Mulligan,et al.  Recurrent Clostridium difficile infection in a patient with selective IgG1 deficiency treated with intravenous immune globulin and Saccharomyces boulardii. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[189]  R. Paladini,et al.  Liver transplantation in HBsAg-positive HBV-DNA--negative cirrhotics: immunoprophylaxis and long-term outcome. , 1996, Liver transplantation and surgery : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[190]  D R Burton,et al.  Recombinant human monoclonal antibodies to Ebola virus. , 1999, The Journal of infectious diseases.

[191]  P. Vespa,et al.  Adjunctive treatment of streptococcal toxic shock syndrome using intravenous immunoglobulin: case report and review. , 1997, The American journal of medicine.

[192]  C. Wittekind,et al.  Liver transplantation in HBs antigen (HBsAg) carriers. Prevention of hepatitis B virus (HBV) recurrence by passive immunization. , 1991, Journal of hepatology.

[193]  E. Simões,et al.  Respiratory syncytial virus immune globulin for prophylaxis against respiratory syncytial virus disease in infants and children with congenital heart disease , 1998 .

[194]  G. Koch,et al.  Efficacy and Safety of Monoclonal Antibody to Human Tumor Necrosis Factor α in Patients With Sepsis Syndrome: A Randomized, Controlled, Double-blind, Multicenter Clinical Trial , 1995 .